SA Asks: Is Eli Lilly or Novo Nordisk a greater funding? (NYSE:LLY)

Two packages of 5 dosing pens each of a fictitious Semiglutin drug used for weight loss (antidiabetic medication or anti-obesity medication) on a blue transparent background. Fictitious package design


Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) now boast the most important marketplace caps in Giant Pharma, due to the wild reputation in their respective GLP-1 medicine for weight-loss and diabetes control.

Novo Nordisk and Lilly have each been within the


Risk Warning: 74-89% of retail investor accounts lose money when trading CFDs . You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money